Literature DB >> 28012282

Low Levels of High-Density Lipoprotein Cholesterol Do Not Predict the Incidence of Type 2 Diabetes in an Iranian High-Risk Population: The Isfahan Diabetes Prevention Study.

Mohsen Janghorbani1, Masoud Amini1, Ashraf Aminorroaya1.   

Abstract

OBJECTIVES: To evaluate the ability of low-level fasting high-density lipoprotein cholesterol (HDLC) to predict the incidence of type 2 diabetes (T2D) in an Iranian high-risk population.
METHODS: Seven-year follow-up data (n = 1,775) in non-diabetic first-degree relatives (FDR) of consecutive patients with T2D aged 30-70 years were analyzed. The primary outcome was the diagnosis of T2D based on repeated oral glucose tolerance test (OGTT). We used Cox proportional hazard models to estimate the hazard ratio (HR) for the incidence of T2D across quartiles of HDLC, and plotted a receiver operating characteristic (ROC) curve to assess discrimination.
RESULTS: The highest quartile compared with the lowest quartile of HDLC was associated with T2D in age- and gender-adjusted models (HR: 0.83, 95% CI: 0.73-0.95). Further adjustment for fasting plasma glucose and cholesterol attenuated the association for T2D incidence (HR: 0.93, 95% CI: 0.80-1.08). The area under the ROC curve for HDLC was 54.1% (95% CI: 50.2-58.0).
CONCLUSIONS: HDLC level was a weak predictor of T2D in an Iranian high-risk population, independent of age and gender.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28012282      PMCID: PMC5553766          DOI: 10.1900/RDS.2016.13.187

Source DB:  PubMed          Journal:  Rev Diabet Stud        ISSN: 1613-6071


  43 in total

1.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

2.  Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.

Authors:  A von Eckardstein; H Schulte; G Assmann
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  JAMA       Date:  1990-06-06       Impact factor: 56.272

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  HDL cholesterol subfractions and risk of developing type 2 diabetes among Pima Indians.

Authors:  A Fagot-Campagna; W C Knowler; K M Narayan; R L Hanson; J Saaddine; B V Howard
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

6.  Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study.

Authors:  Mi Hae Seo; Ji Cheol Bae; Se Eun Park; Eun Jung Rhee; Cheol Young Park; Ki Won Oh; Sung Woo Park; Sun Woo Kim; Won-Young Lee
Journal:  J Clin Endocrinol Metab       Date:  2011-10-12       Impact factor: 5.958

7.  Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.

Authors:  Altan Onat; Gülay Hergenç; Hüseyin Uyarel; Günay Can; Hakan Ozhan
Journal:  Anadolu Kardiyol Derg       Date:  2006-12

8.  Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Authors:  S Matthijs Boekholdt; Benoit J Arsenault; G Kees Hovingh; Samia Mora; Terje R Pedersen; John C Larosa; K M A Welch; Pierre Amarenco; David A Demicco; Andrew M Tonkin; David R Sullivan; Adrienne Kirby; Helen M Colhoun; Graham A Hitman; D John Betteridge; Paul N Durrington; Michael B Clearfield; John R Downs; Antonio M Gotto; Paul M Ridker; John J P Kastelein
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

9.  Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: A post-hoc analysis from the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).

Authors:  Subroto Acharjee; William E Boden; Pamela M Hartigan; Koon K Teo; David J Maron; Steven P Sedlis; William Kostuk; John A Spertus; Marcin Dada; Bernard R Chaitman; G B John Mancini; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2013-08-21       Impact factor: 24.094

10.  Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran.

Authors:  Hadi Harati; Farzad Hadaegh; Navid Saadat; Fereidoun Azizi
Journal:  BMC Public Health       Date:  2009-06-16       Impact factor: 3.295

View more
  1 in total

1.  Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.

Authors:  Shahla Safari; Masoud Amini; Ashraf Aminorroaya; Awat Feizi
Journal:  Lipids Health Dis       Date:  2020-08-23       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.